Uses of Bivicip AG

Bivicip AG is a prescription drug prescribed by a doctor, made in the form of long film-coated tablets. Adhering to the indications, the dose of Bivicip AG will help patients improve the effectiveness of treatment and avoid unwanted side effects.

Bivicip AG medicine contains the following ingredients and excipients:
Ingredients: Ciprofloxacin (in the form of Ciprofloxacin Hydrochloride) content 500mg; Excipients: Sodium Starch Glycolat, Povidone, Microcrystalline Cellulose, Anhydrous Colloidal Silicon Dioxide, Hydroxypropyl Methylcellulose, Titanium Dioxide, Magnesium Stearate, Polyethylene Glycol 6000 and purified water just enough for 1 tablet. Bivicip AG has 4 packaging forms including:
Box of 5 blisters x 10 tablets of Bivicip AG; Box of 10 blisters x 10 tablets of Bivicip AG; Box of 1 bottle of 100 Bivicip AG tablets; Bottle of 500 tablets Bivicip AG.

Bivicip AG is used to treat infections caused by sensitive bacteria such as:
Urinary tract infections; Chronic prostatitis; Lower respiratory tract infections caused by Gram-negative bacteria; Acute sinusitis ; Skin and soft tissue infections; Bone and joint infections; Diarrhea caused by infection; Typhoid fever. Uncomplicated gonorrhea of ​​the cervix and urethra.

Bivicip AG is contraindicated in the following cases:
People with a history of hypersensitivity to Ciprofloxacin components or excipients in Bivicip AG and Quinolone antibiotics; Women who are pregnant or breastfeeding; Children < 18 years old.

How to use: Bivicip AG is taken orally. Patients should take Bivicip AG with a full glass of water, 2 hours after eating.
Dosage:
Treatment of urinary tract infections:
Mild, moderate or uncomplicated cases: Dose 250mg x 2 times/day. Treatment for about 3-7 days; Severe cases and complications: Dose 500mg x 2 times/day. Treatment within 14 days. Treatment of chronic prostatitis:
Mild or moderate disease: Dose 500mg x 2 times/day. Treatment within 28 days. Treatment of lower respiratory tract infections:
Mild, moderate or uncomplicated cases: Dose 500mg x 2 times/day. Treatment within 7 days; Severe cases and complications: Dose 750mg x 2 times/day. Treatment within 14 days. Treatment of acute sinusitis:
Mild and moderate cases: Dose 500mg x 2 times/day. Treatment within 10 days. Treatment of skin and soft tissue infections:
Mild, moderate or uncomplicated cases: Dose 500mg x 2 times/day. Treatment within 7 days; Severe cases and complications: Dose 750mg x 2 times/day. Treatment within 14 days. Treatment of bone and joint infections:
Mild, moderate or uncomplicated cases: Dose 500mg x 2 times/day. Treatment for 4 weeks; Severe cases and complications: Dose 750mg x 2 times/day. Treatment within 6 weeks. Treatment of diarrhea caused by infections:
Mild to severe cases: Dose 500mg x 2 times/day. Treatment within 5-7 days. Treatment of typhoid fever:
Mild to moderate cases: Dose 500mg x 2 times/day. Treatment for 10 days. Treatment of urethral and cervical gonorrhea:
Uncomplicated: 500mg single dose. Note: Dosage adjustment is required in patients with renal impairment.
Dosage of Bivicip AG above is for reference only. The specific dose of Bivicip AG depends on the condition and the progression of the disease. To get the right dose of Bivicip AG, patients should consult their doctor or medical professional.

Using Bivicip AG can cause some unwanted effects in the organ systems such as:
Digestive system: Abdominal pain, nausea/vomiting, indigestion, diarrhea and pseudomembranous colitis. Central nervous system: Dizziness, headache, hallucinations, insomnia, psychosis, depression, visual disturbances, nightmares and convulsions. Skin: Pruritus, erythema, vasculitis, Steven Johnson syndrome, erythema multiforme and photosensitivity. Systemic anaphylactic reaction. Eosinophilia, thrombocytopenia, leukopenia, hemolytic anemia (very rare) and agranulocytosis. Temporarily increased serum creatinine, bilirubin and urea. Jaundice, elevated liver enzymes and hepatitis. Renal failure, crystalluria, interstitial nephritis and hematuria. Heart beats fast. Joint discomfort, Achilles tendonitis, and muscle pain. The effects of Bivicip AG are usually mild and moderate. However, serious side effects of Bivicip AG can still occur, so it should not be subjective. If you experience these symptoms, the patient should stop using Bivicip AG and notify the doctor for appropriate treatment.

Be careful when using Bivicip AG for people with a history of central nervous system disorders, epilepsy, impaired liver and kidney function, G6PD deficiency and myasthenia gravis. Long-term use of Bivicip AG may cause overgrowth of susceptible bacteria. In this case, it is necessary to have an antibiotic chart and appropriate treatment measures. Patients should limit exposure to sunlight and ultraviolet rays during treatment with Bivicip AG. If photosensitivity occurs, Bivicip AG should be discontinued. It is not recommended to use Bivicip AG for children from 1 to 17 years old because it can cause cartilage degeneration. Elderly people with impaired liver and kidney function need to adjust the dose of Bivicip AG accordingly. Bivicip AG can cause side effects such as dizziness, lightheadedness, so it should be used with caution when used by people who drive and operate machinery.

Missed dose:
In case of missing dose of Bivicip AG, it is advisable to supplement as soon as possible. However, if it is almost time for the next dose, skip the missed dose of Bivicip AG and use a new dose. Overdosage:
When Bivicip AG overdose is used, it can cause headache, drowsiness, disorientation, abdominal pain, dizziness, slurred speech, nausea/vomiting, tremors, diarrhea and problems. about the kidney. Patients need to stop the drug immediately and go to the nearest medical facility for timely treatment. Above is all information about Bivicip AG, patients need to carefully read the instructions for use, consult a doctor / pharmacist before using. Absolutely do not arbitrarily buy Bivicip AG for home treatment because there may be unwanted side effects.